Danish Firm Nuevolution Lends Screening Technology to Epigenetics Therapeutics Project

Nuevolution will use its Chemetics technology to screen hundreds of millions of small molecules as part of a consortium that also includes EpiTherapeutics, ExpreS2ion Biotechnologies, and the research group of Kristian Helin at the Biotech Research & Innovation Centre at the University of Copenhagen.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.